January 09, 2018
Rose
Pleasanton, California-based Spirosure (previously known as Spirometrix) has raised $15 million in Series C-2 financing for its breath analysis device, according to a statement. The funding round was led by returning investor NGK Spark Plugs Co. Ltd. of Japan, as well as other unnamed investors.
from MobiHealthNews http://ift.tt/2ErUPBD
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment